Top 10 biotech hubs in the US

In biotech, success is often shaped as much by location as it is by innovation.

While the US remains the world’s largest life sciences market, talent and, funding are concentrated in a relatively small number of locations. This includes established giants like Boston and San Francisco along with rapidly growing biotech centers.

For employers, choosing the right hub can significantly impact on growth. The strongest markets provide access to specialist talent and investor networks, while less established hubs may offer lower costs and less competition for skilled professionals.

In this guide, we rank the leading biotech hubs in the US for 2026, assessing each market on talent availability, investment activity and innovation output.

What defines a biotech hub in 2026

A successful biotech hub will tend to have five key characteristics:

• Talent density supported by leading universities, research institutions and experienced life sciences professionals.
• Access to funding from venture capital firms, government agencies and private investors.
• A thriving life sciences ecosystem, with established pharmaceutical and biotech companies emerging startups that create opportunities for collaboration.
• The right infrastructure, including incubators, laboratory space and manufacturing facilities.
• A proven track record of innovation, measured through research activity, patents, clinical trials and new therapies.

The top biotech hubs in the US (2026)

Tier 1

1. Boston/Cambridge

Boston and Cambridge remain the undisputed leaders among biotech hubs in the US. Home to world renowned institutions such as Harvard University, MIT, and Massachusetts General Hospital, the region continues to attract significant investment and produce groundbreaking scientific innovation.

MassBio reports that Massachusetts had 63.2 million sq ft of lab and GMP space in 2025, while Massachusetts based companies attracted $2.75 billion in VC funding in the first half of 2025.

What makes it unique?

Its greatest strength is the density of academia, research, venture capital, and biotech companies within a relatively small geographic area. Few locations globally can match their concentration of scientific expertise and innovation. The region is particularly strong in drug discovery, oncology, cell and gene therapy, neuroscience, immunology and advanced therapeutics.

Hiring insight: While talent availability is strong, competition is exceptionally intense. Employers often compete simultaneously with major pharmaceutical organisations, venture backed startups, and rapidly scaling biotech firms. Demand is particularly high for cell and gene therapy specialists, clinical development professionals, regulatory experts, and computational biologists, leading to significant salary pressure.

2. San Franciso Bay Area

The combination of biotechnology and technology has helped make the San Francisco Bay Area one of the most influential biotech hub in the world.

California remains one of the most important life sciences markets in the US, with Biocom reporting that the state’s life sciences industry generated $394 billion in total economic output, supported more than 1.08 million jobs and directly employed 406,565 workers in 2025.

What makes it unique?

The Bay Area’s biggest advantage is the merging of biotech, artificial intelligence, software engineering and data science. This combination has helped position the region at the forefront of AI-driven drug discovery and precision medicine.

Hiring insight: Competition for experienced professionals remains extremely high, particularly in bioinformatics, machine learning, computational biology, translational research and data led drug discovery. Salary expectations are among the highest in the country.

3. San Diego

Built on a foundation of academic research and entrepreneurial innovation, San Diego has become one of the most influential biotech hubs in the US. Institutions including UC San Diego, the Salk Institute and Scripps Research help fuel a vibrant life sciences network that spans biotech, pharmaceuticals and medical devices. The region’s strong talent pipeline and collaborative business environment have helped it remain a key destination for investment and growth.

What makes it unique?

San Diego combines strong scientific research with a highly collaborative biotech community. It is particularly recognised for immunology, drug development, diagnostics, cell therapy and therapeutics. The city also offers a good quality of life, which helps employers attract candidates from more expensive or competitive markets.

Hiring insight: Employers benefit from a strong local talent pool, but competition remains significant. Scientists with expertise in biologics, clinical research, translational medicine, quality, manufacturing and regulatory affairs are especially sought after.

Tier 2

4. North Carolina

Once known primarily for its academic excellence, the Research Triangle has evolved into one of the fastest growing biotech hubs in the US. Backed by Duke University, UNC Chapel Hill and NC State University, the region pairs a deep pool of scientific talent with sustained investment in biopharma manufacturing, therapeutics and life sciences infrastructure.

What makes it unique?

North Carolina’s biggest advantage is its ability to combine academic excellence with large scale biopharmaceutical manufacturing. The region is particularly strong in biologics, vaccines, gene therapy, contract development and manufacturing, and clinical research. Compared with Tier 1 markets, employers can often access talent at a lower cost while benefiting from a highly collaborative life sciences landscape.

Hiring insight: Demand remains strong for manufacturing professionals, process development scientists, quality specialists, clinical operations professionals and regulatory experts. While competition is lower than in Boston or the Bay Area, employers still face challenges attracting experienced talent in specialist bioprocessing and advanced therapeutics roles.

5. Biotech Capital Region (Washington DC/Maryland/Virginia)

Few biotech markets are as closely connected to the US healthcare and regulatory landscape as the BioHealth Capital Region. Spanning Maryland, Virginia and Washington DC, the region has built a thriving network around federal agencies, research institutions and public-private partnerships. Its concentration of scientific expertise and government-backed innovation makes it a critical center for biotech growth.

BioHealth Innovation states that the region is anchored by NIH, FDA, BARDA, ARPA-H and world-class academic centers, and is home to more than 2,300 life science companies and 78 federal laboratories.

What makes it unique?

The region’s defining advantage is its connection to federal research, regulation and public health infrastructure. This makes it attractive for companies working in vaccines, infectious disease, diagnostics, government-backed research and regulated life sciences products. It also benefits from strong public-private collaboration across biotechnology, diagnostics, digital health, biomanufacturing and therapeutics.

Hiring insight: The BioHealth Capital Region offers access to specialists in regulatory affairs, clinical research, quality, manufacturing and government-funded science. However, employers may face competition from federal agencies, contractors, research institutions and established pharma organisations.

6. New York / New Jersey

Few US biotech markets can match the scale and commercial strength of the New York and New Jersey corridor. Bringing together leading research institutions, major hospitals, global pharmaceutical companies and financial centres, the region creates opportunities across every stage of drug development while providing access to a highly experienced workforce.

What makes it unique?

New York offers growing biotech startup activity, strong academic research and access to capital, while New Jersey brings deep pharmaceutical heritage and established industry infrastructure. Together, they create a diverse network spanning biotech, pharma, diagnostics, digital health, translational medicine, clinical operations and commercial functions.

Hiring insight: The New York/New Jersey market offers a broad talent pool, particularly for clinical, commercial, regulatory, medical affairs and corporate roles. However, the region is expensive and highly competitive. Employers may need to differentiate themselves on mission, flexibility, progression and compensation.

7. Philadelphia

Driven by a powerful combination of academic research, healthcare innovation and cell and gene therapy expertise, Philadelphia has quietly become one of the most exciting biotech markets in the US. The region is anchored by leading institutions including the University of Pennsylvania, Children’s Hospital of Philadelphia and Jefferson Health, which continue to generate pioneering research and attract investment. While often overshadowed by Boston and the Bay Area, Philadelphia has carved out a strong reputation as a centre for translational science and next-generation therapeutics.

What makes it unique?

 Philadelphia is widely recognised as a leader in cell and gene therapy, supported by groundbreaking research, a growing biotech hub and strong links between academia and industry. The region offers access to high-quality talent and research infrastructure while maintaining lower operating costs than some Tier 1 markets.

Hiring insight: Demand is particularly strong for professionals in cell and gene therapy, clinical development, regulatory affairs and translational research. Competition for specialist talent is increasing, but employers may find greater hiring flexibility and lower salary pressure than in Boston or San Francisco.

Tier 3

8. Seattle

8Seattle has steadily built a reputation as one of the most innovative life sciences markets in the Pacific Northwest, combining world-class research with deep expertise in technology and data science. Supported by organisations such as the University of Washington, Fred Hutchinson Cancer Center and the Allen Institute, the region continues to attract investment across biotechnology, healthcare and precision medicine. Its growing biotech network is increasingly drawing attention from employers looking beyond traditional hubs.

What makes it unique?

Seattle’s key advantage lies in the intersection of biotech and technology. The region benefits from strong capabilities in computational biology, genomics, artificial intelligence and data-driven healthcare, creating opportunities in precision medicine and advanced therapeutics.

Hiring insight: Demand remains high for bioinformatics specialists, computational biologists, data scientists and translational researchers. Competition for talent can extend beyond biotech, with employers also competing against major technology companies for highly skilled professionals.

9. Los Angeles and Orange County

Long known for their strengths in healthcare and medical technology, Los Angeles and Orange County are becoming increasingly important players in the biotech landscape. The region benefits from a large population, leading research institutions and growing investment activity, helping to support a diverse life sciences network. As more companies establish operations in California, the area’s influence within biotech continues to expand.

What makes it unique?

The region combines biotechnology, medical devices, diagnostics and digital health within one of the largest healthcare markets in the country. Institutions such as UCLA, USC and UC Irvine provide a strong talent pipeline, while the area’s entrepreneurial culture continues to encourage innovation.

Hiring insight: Employers can access talent across research, clinical operations, medical devices and digital health, although the market can be fragmented compared with more established biotech clusters. Demand is growing for professionals with expertise in diagnostics, product development and healthcare technology.

10. Chicago and the Midwest corridor

The Midwest is increasingly emerging as a compelling alternative to traditional coastal biotech hubs. Chicago sits at the centre of a growing life sciences corridor supported by major universities, healthcare systems and expanding research infrastructure. While the region may not yet match the scale of Boston or San Diego, it offers significant potential for companies seeking access to talent without the costs associated with larger biotech markets.

What makes it unique?

Chicago’s strength comes from its combination of academic research, healthcare innovation and affordability. The region is developing capabilities across therapeutics, medical devices, diagnostics and biomanufacturing, while benefiting from a large and diverse workforce.

Hiring insight: Salary expectations are often more moderate than in leading coastal hubs, helping employers stretch recruitment budgets further. Demand is rising for professionals in R&D, quality, manufacturing, regulatory affairs and clinical operations as the region’s biotech cluster continues to establish.

Key trends shaping biotech hubs in 2026

Talent is concentrating in fewer hubs

Despite the growth of emerging biotech markets, talent remains heavily concentrated in a handful of leading hubs. Boston, San Francisco and San Diego continue to attract the highest concentration of skilled professionals, investors, research institutions and biotech employers.

This creates a snowball effect, talent attracts companies, companies attract funding , and funding attracts even more talent. For employers, these Tier 1 hubs remain centres of innovation, but they also present some of the industry’s most competitive hiring conditions.

AI is reshaping location advantages

Artificial intelligence is becoming a core part of biotech, especially in drug discovery, data analysis, precision medicine and clinical development.

Locations that combine life sciences expertise with strong technology clusters, particularly the Bay Area, Boston and San Diego, are well positioned to benefit from this shift. As a result, demand continues to grow for professionals with expertise in bioinformatics, machine learning, computational biology and data science.

Secondary hubs are rising

While the industry’s largest markets continue to dominate, a growing number of secondary biotech hubs are proving that innovation doesn’t have to be concentrated in a handful of cities.

Regions such as North Carolina, Philadelphia and the BioHealth Capital Region are attracting investment by offering strong talent pipelines, expanding infrastructure and lower levels of hiring competition than many Tier 1 markets. For employers, these locations can provide a compelling balance of talent and growth potential, alongside specialist strengths in areas such as biomanufacturing, cell and gene therapy, and regulatory science.

What this means for hiring in life sciences

For employers

Hiring strategy must align with location

The market you hire in can have a major impact on recruitment outcomes. While Tier 1 hubs offer access to some of the deepest life sciences talent pools in the world, they also come with fierce competition and rising salary expectations. Employers need to balance access to talent against the realities of cost and competition.

Expanding beyond Tier 1 can reduce hiring pressure

Looking beyond Boston, San Francisco and San Diego can open up access to highly skilled talent with less competition. Growing markets such as North Carolina, Philadelphia and the BioHealth Capital Region are attracting investment and giving employers new options for scaling teams more efficiently.

Demand for specialist skills is increasing

Across almost every biotech hub, competition is increasing for highly specialised professionals. These include:

• Cell and gene therapy specialists
• Regulatory affairs professionals
• Clinical development experts
• Quality assurance and quality control professionals
• Biomanufacturing and process development specialists
• Computational biologists
• Bioinformatics professionals
• AI-biotech and data science specialists

As demand for these professionals continue to grow, employers can no longer rely on broad recruitment approaches. The most successful hiring strategies are targeted and tailored to the talent strengths of each biotech hub.

For candidates

Career opportunities are still hub driven

For many life sciences professionals, major biotech hubs continue to be the centre of career growth. Boston, the Bay Area and San Diego offer access to a high concentration of employers, investment, research activity and groundbreaking scientific projects. For candidates looking to be more specialised, build their network or gain experience in emerging technologies, these hubs remain highly attractive.

Emerging hubs offer faster progression

While established hubs often attract the most attention, emerging biotech markets can offer compelling career advantages of their own. Regions such as North Carolina, Philadelphia and Seattle are creating new opportunities for scientists and life sciences professionals to take on broader responsibilities and grow their careers in expanding organisations.

Ultimately, the right location depends on an individual’s career ambitions and preferred working environment. For some, that may be a global biotech powerhouse. For others, it may be a fast-growing hub where they can help shape the industry’s next chapter.

How to choose the right biotech hub

Location can be a competitive advantage. While established hubs such as Boston, San Francisco and San Diego offer unrivalled access to talent and investment, they also come with intense hiring competition and higher salary expectations. Meanwhile, fast-growing markets such as North Carolina, Philadelphia and Seattle are attracting increasing investment and offering employers new opportunities to access specialist talent.

When assessing a biotech hub, employers should look beyond reputation alone. Talent availability, hiring competition, infrastructure, research partnerships and access to funding can all influence long-term success.

Ultimately, the best biotech hub isn’t necessarily the largest. It’s the one that best aligns with your scientific focus, hiring needs and growth ambitions.

Hiring in US biotech hubs with R&D Partners

Building life sciences teams requires more than simply posting vacancies in the right location.

Whether you’re hiring in Boston, San Diego, the Bay Area, North Carolina, or one of the country’s fastest-growing biotech markets, access to specialist talent remains highly competitive.

At R&D Partners, we help life sciences organisations identify and secure the talent they need to grow across the most important biotech hubs in the US.

Looking to hire in one of the top biotech hubs in the US? Contact our team today: https://www.r-dpartners.com/contact/